Authors: Storm Johnson (Future Science Group)
UCLA researchers reveal that 30% of people treated for COVID-19 developed Long COVID and link factors correlated to the likelihood of developing the syndrome.
Researchers from the University of California, Los Angeles (UCLA; CA, USA) set out to discover the proportion of people treated for COVID-19 who developed Post-Acute Sequelae of COVID-19 (PASC), also known as ‘Long COVID’. Of the 309 people with Long COVID studied, fatigue and shortness of breath were the most persistent symptoms (31% and 15%, respectively) in hospitalized patients and loss of sense of smell (16%) in outpatients. These results could help to improve our management and understanding of the condition.